Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
33%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
PJP
29
HOLDINGS
34%
ALSO IN MEDX
MEDX
28
HOLDINGS
36%
ALSO IN PJP
SECTOR DRIFT (PJP minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 5.2% | 9.6% | 5.2% |
|
ELI LILLY & CO | 5.1% | 14.5% | 5.1% |
|
JOHNSON & JOHNSON | 5.0% | 4.9% | 4.9% |
|
AMGEN INC | 4.7% | 3.7% | 3.7% |
|
PFIZER INC | 4.7% | 3.5% | 3.5% |
PJP Overweight Relative to MEDX
|
ABBOTT LABORATORIES | 5.0% |
|
GILEAD SCIENCES INC | 4.9% |
|
TRAVERE THERAPEUTICS, INC. | 3.6% |
|
UNITED THERAPEUTICS CORP | 3.5% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | 2.9% |
|
BIOSANTE PHARMACEUTICALS INC | 2.9% |
|
CORCEPT THERAPEUTICS INC | 2.8% |
|
PACIRA PHARMACEUTICALS INC | 2.8% |
|
OCULAR THERAPEUTIX INC | 2.8% |
|
LIGAND PHARMACEUTICALS-CL B | 2.8% |
PJP Underweight Relative to MEDX
|
ELI LILLY & CO | -9.4% |
 |
NOVARTIS AG-ADR | -6.8% |
|
ALNYLAM PHARMACEUTICALS INC | -6.6% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.2% |
|
IONIS PHARMACEUTICALS, INC. | -4.5% |
|
ABBVIE INC | -4.4% |
 |
ALKERMES PLC | -3.6% |
|
CRISPR THERAPEUTICS AG | -3.4% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.6% |
|
BRISTOL-MYERS SQUIBB CO | -1.8% |